Furthermore, overexpression of OAS1 affects survival in lung adenocarcinoma (LUAD) patients and immune cell infiltration, suggesting it may serve as a potential prognostic marker for LUAD (Wang et al., 2024). This evidence concerns the gene OAS1 and lung adenocarcinoma.